<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04385758</url>
  </required_header>
  <id_info>
    <org_study_id>20-001011</org_study_id>
    <nct_id>NCT04385758</nct_id>
  </id_info>
  <brief_title>Community Paramedicine Program to Improve Diabetes Care Quality, Equity, and Outcomes in Southeast Minnesota</brief_title>
  <official_title>Community Paramedicine Program to Improve Diabetes Care Quality, Equity, and Outcomes in Southeast Minnesota</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is evaluate the effectiveness of Diabetes-REM (Rescue, Engagement,
      and Management), a comprehensive community paramedic (CP) program to support adults in rural
      Minnesota (Mower and Freeborn counties) who have uncontrolled diabetes (HbA1c ≥ 9%) and have
      experienced an emergency department (ED) visit or hospitalization for any cause in the prior
      6 months.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">July 13, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diabetes Distress (using DDS)</measure>
    <time_frame>1 month</time_frame>
    <description>The level of diabetes-related distress that is expressed by patient participants using the Diabetes Distress Scale (the DDS contains 17 questions, with responses ranging from &quot;Not a Problem&quot; (1) to &quot;A Very Serious Problem&quot; (6). Total scores use the sum of all responses divided by 17, with a mean item score of 3 or higher (moderate distress) indicating distress worthy of clinical attention.)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes Distress (using DDS)</measure>
    <time_frame>4 months</time_frame>
    <description>The level of diabetes-related distress that is expressed by patient participants using the Diabetes Distress Scale (the DDS contains 17 questions, with responses ranging from &quot;Not a Problem&quot; (1) to &quot;A Very Serious Problem&quot; (6). Total scores use the sum of all responses divided by 17, with a mean item score of 3 or higher (moderate distress) indicating distress worthy of clinical attention.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Confidence in Diabetes Self-Management (using DSMQ)</measure>
    <time_frame>1 and 4 months</time_frame>
    <description>The level of confidence patient participants express in managing their diabetes using the Diabetes Self-Management Questionnaire (DSMQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life (using EQ-5D)</measure>
    <time_frame>1 and 4 months</time_frame>
    <description>Patients participants' self-reported health-related quality of life using the EuroQol 5-D (also known as EQ-5D; an instrument for measuring quality of life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Reported Hypoglycemia and Hyperglycemia</measure>
    <time_frame>1 and 4 months</time_frame>
    <description>Incidences of hypoglycemia (blood glucose &lt;70 mg/dL and &lt;54 mg/dL) and hyperglycemia (blood glucose ≥250 mg/dL) as reported by patient participants</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Diabetes-REM Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diabetes-REM Program</intervention_name>
    <description>A comprehensive community paramedicine management program designed to support adults with uncontrolled diabetes and a recent emergency department visit or hospitalization</description>
    <arm_group_label>Diabetes-REM Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (Patients):

          -  Most recent hemoglobin A1c ≥ 9% within the last 2 years.

          -  Age ≥ 18 years old.

          -  Type 1 or type 2 diabetes.

          -  Paneled to a Mayo Clinic or MCHS practice.

          -  Able to provide informed consent.

          -  Proficient in English.

          -  Community-dwelling.

          -  Live in Mower or Freeborn counties.

        Inclusion Criteria (Paramedics):

        •Community Paramedics who delivered the Diabetes-REM intervention.

        Exclusion Criteria:

          -  Cognitive impairment precluding informed consent.

          -  Lack of conversational English skills.

          -  Resident of a long-term care facility.

          -  Enrolled in hospice.

          -  Enrolled in a care coordination or disease management program.

          -  Advanced or terminal illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rozalina McCoy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Rozalina G. McCoy</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Community paramedicine</keyword>
  <keyword>Diabetes mellitus</keyword>
  <keyword>Diabetes distress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

